Octapharma Competitors and Similar CompaniesClear all

Octapharma's competitors and similar companies include Grifols, CSL Behring, CR Sanjiu and Patheon.

	Octapharma Octapharma is one of the largest human protein manufacturers, developing and producing human proteins from human plasma and human cell lines.	Grifols Grifols is a pharmaceutical and chemical manufacturer.	CSL Behring CSL Behring is a provider of life-saving medicines.	CR Sanjiu China Resources Sanjiu Medical & Pharmaceutical (CR Sanjiu, 华润三九医药股份有限公司)	Patheon Patheon is a company that provides commercial manufacturing and pharmaceutical development services.
Founding Date	Founding Date 1983	Founding Date 1909	Founding Date 1904	Founding Date 1985	Founding Date 2014
Type	Type Private	Type Public	Type Subsidiary	Type Public	Type Subsidiary
Tags	Tags Manufacturing & Industrial drug development pharma	Tags Healthcare clinics healthtech hospitals pharma therapy	Tags Healthcare biotech drug development pharma	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma
Locations	Locations Lachen, CH HQ Pyrmont, AU Wien, AT Baku, AZ Minsk, BY Anderlecht, BE see more	Locations Sant Cugat del Vallès, ES HQ Buenos Aires, AR Clayton South, AU São Paulo, BR Mississauga, CA Las Condes, CL see more	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more	Locations Shenzhen, CN HQ	Locations Mississauga, CA HQ
Employees	Employees 12,000	Employees 23,800	Employees 7,5692% decrease	Employees 20,031	Employees 6,500
Valuation ($)	Valuation ($) N/A	Valuation ($) 6.7 b	Valuation ($) N/A	Valuation ($) 8.2 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) €2.5b (FY, 2021)	Revenue (est.) €7.5b (FY, 2025)	Revenue (est.) $7.9b (FY, 2020)	Revenue (est.) ¥30.1b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods €1.7b (FY, 2021)	Cost of goods €4.2b (FY, 2025)	Cost of goods N/A	Cost of goods ¥14.5b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit €808.2m (FY, 2021)	Gross profit €3.3b (FY, 2025)	Gross profit $4.5b (FY, 2020)	Gross profit ¥16.7b (FY, 2025)	Gross profit N/A
Net income	Net income €438.3m (FY, 2021)	Net income €500m (FY, 2025)	Net income N/A	Net income ¥4.2b (FY, 2025)	Net income N/A
Operating ⚠
Countries	Countries N/A	Countries 110 (H2, 2021)	Countries 100 (Dec, 2020)	Countries N/A	Countries N/A
Plasma Collection Centers	Plasma Collection Centers N/A	Plasma Collection Centers 366 (FY, 2021)	Plasma Collection Centers 275 (Sep, 2020)	Plasma Collection Centers N/A	Plasma Collection Centers N/A
Trademark Applications	Trademark Applications N/A	Trademark Applications N/A	Trademark Applications 1 (Dec, 2020)	Trademark Applications N/A	Trademark Applications 2 (Feb, 2024)
Trademarks	Trademarks N/A	Trademarks N/A	Trademarks 4 (Dec, 2020)	Trademarks N/A	Trademarks 50 (Feb, 2024)